A prospective observational study on the correlation between hormonal profiles and acne severity in women with adult-onset acne.
DOI:
https://doi.org/10.51168/sjhrafrica.v6i9.2194Keywords:
Adult-onset acne, Hormonal profile, Free testosterone, Sex Hormone–Binding Globulin, Polycystic Ovary Syndrome, Acne severity, Homeostatic Model Assessment of Insulin ResistanceAbstract
Background:
Adult-onset acne (AOA) is increasingly prevalent among women and is often refractory to conventional therapy. Hormonal fluctuations, hyperandrogenemia, and metabolic disturbances are recognized contributors, yet the correlation between hormonal profiles and acne severity remains under-defined in Indian women. To evaluate the relationship between serum hormonal parameters and the severity of acne in women presenting with adult-onset acne.
Methods:
A prospective observational study was conducted among 100 women aged 18–40 years with clinically diagnosed AOA attending a tertiary dermatology OPD. Detailed clinical assessment, menstrual and family history, and Global Acne Grading System (GAGS) scoring were performed. Fasting serum levels of total and free testosterone, DHEA-S, SHBG, LH, FSH, prolactin, TSH, 17-hydroxyprogesterone, and fasting insulin (HOMA-IR) were estimated. Correlations between hormonal parameters and acne severity were analyzed using Spearman’s rank test and multivariate logistic regression.
Results:
The mean age of participants was 26.8 ± 4.9 years. Menstrual irregularity and PCOS were observed in 38% and 41% respectively. Based on GAGS, 28% had mild, 46% moderate, and 26% severe acne. Elevated free testosterone (34%), total testosterone (29%), and reduced SHBG (26%) were the most frequent hormonal abnormalities. Acne severity correlated positively with free testosterone (ρ = 0.41, p < 0.001), total testosterone (ρ = 0.32, p = 0.002), DHEA-S (ρ = 0.29, p = 0.004), and LH/FSH ratio (ρ = 0.24, p = 0.016), while SHBG showed an inverse correlation (ρ = −0.33, p = 0.001). PCOS and insulin resistance significantly amplified the severity.
Conclusion:
Hormonal imbalance, particularly elevated free testosterone and low SHBG, plays a crucial role in the pathogenesis and severity of AOA. Recognition of underlying endocrine dysfunction is essential for comprehensive management.
Recommendations:
Routine hormonal evaluation should be incorporated in women presenting with persistent or severe AOA to guide individualized hormonal or metabolic therapy, ensuring optimal and sustained outcomes.
References
Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, Freeman EE, Keri JE, Stein Gold LF, Tan JKL, Tollefson MM, Weiss JS, Wu PA, Zaenglein AL, Han JM, Barbieri JS. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024 May;90(5):1006.e1-1006.e30. doi: 10.1016/j.jaad.2023.12.017. Epub 2024 Jan 30. PMID: 38300170. https://doi.org/10.1016/j.jaad.2023.12.017
Telkkälä A, Sinikumpu SP, Huilaja L. Etiology of Adult Female Acne-Systematic Review. Health Sci Rep. 2025 Apr 30;8(5):e70697. Doi: 10.1002/hsr2.70697. PMID: 40309637; PMCID: PMC12042216. https://doi.org/10.1002/hsr2.70697
Dias da Rocha MA, Saint Aroman M, Mengeaud V, Carballido F, Doat G, Coutinho A, Bagatin E. Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence. Int J Womens Health. 2024 Apr 18;16:663-678. doi: 10.2147/IJWH.S431523. PMID: 38650835; PMCID: PMC11034510. https://doi.org/10.2147/IJWH.S431523
Carmina E, Dreno B, Lucky WA, Agak WG, Dokras A, Kim JJ, Lobo RA, Ramezani Tehrani F, Dumesic D. Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. J Endocr Soc. 2022 Feb 6;6(3):bvac003. Doi: 10.1210/jendso/bvac003. Erratum in: J Endocr Soc. 2023 Jan 24;7(3):bvad006. doi: 10.1210/jendso/bvad006. PMID: 35155970; PMCID: PMC8826298. https://doi.org/10.1210/jendso/bvad006
Zhang R, Zhou L, Lv M, Yue N, Fei W, Wang L, Liu Z, Zhang J. The relevance of Sex Hormone Levels and Acne Grades in Patients with Acne Vulgaris: A Cross-Sectional Study in Beijing. Clin Cosmet Investig Dermatol. 2022 Oct 18;15:2211-2219. Doi: 10.2147/CCID.S385376. PMID: 36281268; PMCID: PMC9587737. https://doi.org/10.2147/CCID.S385376
Anaje CC, Onyekonwu CL, Ozoh GA, Ezejiofor OI. Assessment of serum androgen levels in women with acne vulgaris in Southeastern Nigeria: a cross-sectional study. Pan Afr Med J. 2022 Mar 18;41:227. doi: 10.11604/pamj.2022.41.227.32892. PMID: 35721630; PMCID: PMC9167485. https://doi.org/10.11604/pamj.2022.41.227.32892
Gruszczyńska M, Sadowska-Przytocka A, Szybiak W, Więckowska B, Lacka K. Insulin Resistance in Patients with Acne Vulgaris. Biomedicines. 2023 Aug 18;11(8):2294. doi: 10.3390/biomedicines11082294. PMID: 37626790; PMCID: PMC10452885. https://doi.org/10.3390/biomedicines11082294
Hasrat NH, Al-Yassen AQ. The Relationship Between Acne Vulgaris and Insulin Resistance. Cureus. 2023 Jan 26;15(1):e34241. doi: 10.7759/cureus 34241. PMID: 36852374; PMCID: PMC9964714.
Ben Abdessalem F, Ach T, Fetoui NG, Mraihi E, Abdelkarim AB. Characterizing clinical and hormonal profiles of acne in North African women with polycystic ovary syndrome. Arch Dermatol Res. 2024 Oct 26;316(10):711. Doi: 10.1007/s00403-024-03466-3. PMID: 39460776. https://doi.org/10.1007/s00403-024-03466-3
Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi Yarandi R, Saei Ghare Naz M, Carmina E. Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2021 May;37(5):392-405. doi: 10.1080/09513590.2020.1859474. Epub 2020 Dec 23. PMID: 33355023. https://doi.org/10.1080/09513590.2020.1859474
Layton AM, Gupta G, Seukeran D, Maruthappu T, Gaillard S, Whitehouse H, Ali FR, Razzaque A, Al-Niaimi F, Copperwheat S. What's New After NICE Acne Guidelines. Dermatol Ther (Heidelb). 2024 Oct;14(10):2727-2738. doi: 10.1007/s13555-024-01275-0. Epub 2024 Sep 21. PMID: 39305432; PMCID: PMC11480286. https://doi.org/10.1007/s13555-024-01275-0
Altunel CT, Tatlıcan S. The clinical predictors of biochemical hyperandrogenemia and its relation to treatment resistance in women with acne. Postepy Dermatol Alergol. 2025 Feb;42(1):54-61. doi: 10.5114/ada 2024.144480. Epub 2024 Oct 15. PMID: 40114774; PMCID: PMC11921917. https://doi.org/10.5114/ada.2024.144480
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Mohan Krishna Reddy Thotli, Dr. Vani Gunda, Dr. Gadala Gamana

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
















